Literature DB >> 21036152

Regulation of the promoter region of the human adiponutrin/PNPLA3 gene by glucose and insulin.

Sharleen M Rae-Whitcombe1, Darnell Kennedy, Matt Voyles, Mary P Thompson.   

Abstract

The adiponutrin/PNPLA3 gene is highly expressed in adipose tissue and liver. Its expression is down-regulated by fasting and rapidly induced by refeeding a high carbohydrate diet. We aimed to determine whether the promoter region of adiponutrin is regulated by glucose and insulin. Endogenous adiponutrin mRNA was increased in mouse 3T3-L1 and human SGBS adipocytes and in human HepG2 cells cultured in 25 mM glucose compared to absence of glucose. A 3100 bp 5'-upstream region of the human adiponutrin gene was cloned into a luciferase reporter plasmid and used in transient transfection studies. Promoter activity was up-regulated by 25 mM glucose, 4.7-fold in HepG2 cells and 2-fold in CHO cells. The effect was shown in CHO cells to be concentration dependent and to depend on glucose metabolism as a non-metabolisable analogue was without effect. In CHO cells constitutively expressing human insulin receptor (CHO-IR), there was a concentration dependent increase of promoter activity by insulin in the presence of glucose. Cotransfection with an expression plasmid for upstream stimulatory factor 2 (USF2), increased promoter activity 1.6-fold in CHO-IR cells. The combined effect of insulin and USF2 (2.3-fold) was greater than the individual effects. Cotransfection of carbohydrate-response element binding protein did not elicit any induction of promoter activity. These results point to potential mechanisms for the observed in vivo nutritional regulation of adiponutrin expression and its up-regulation in fatty liver and by obesity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036152     DOI: 10.1016/j.bbrc.2010.10.106

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Metabolic profiling reveals that PNPLA3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cells.

Authors:  Hae-Ki Min; Silvia Sookoian; Carlos J Pirola; Jianfeng Cheng; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

3.  Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.

Authors:  Lei Hao; Kyoko Ito; Kuan-Hsun Huang; Sudathip Sae-tan; Joshua D Lambert; A Catharine Ross
Journal:  Metabolism       Date:  2014-06-21       Impact factor: 8.694

Review 4.  PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.

Authors:  Li-Zhen Chen; Yong-Ning Xin; Ning Geng; Man Jiang; Ding-Ding Zhang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

6.  PNPLA3 mediates hepatocyte triacylglycerol remodeling.

Authors:  Hanna Ruhanen; Julia Perttilä; Maarit Hölttä-Vuori; You Zhou; Hannele Yki-Järvinen; Elina Ikonen; Reijo Käkelä; Vesa M Olkkonen
Journal:  J Lipid Res       Date:  2014-02-07       Impact factor: 5.922

7.  Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.

Authors:  Manju Kumari; Gabriele Schoiswohl; Chandramohan Chitraju; Margret Paar; Irina Cornaciu; Ashraf Y Rangrez; Nuttaporn Wongsiriroj; Harald M Nagy; Pavlina T Ivanova; Sarah A Scott; Oskar Knittelfelder; Gerald N Rechberger; Ruth Birner-Gruenberger; Sandra Eder; H Alex Brown; Guenter Haemmerle; Monika Oberer; Achim Lass; Erin E Kershaw; Robert Zimmermann; Rudolf Zechner
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

8.  The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Authors:  Hans Dieter Nischalke; Cordula Berger; Carolin Luda; Thomas Berg; Tobias Müller; Frank Grünhage; Frank Lammert; Martin Coenen; Benjamin Krämer; Christian Körner; Natascha Vidovic; Johannes Oldenburg; Jacob Nattermann; Tilman Sauerbruch; Ulrich Spengler
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

Review 9.  Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives.

Authors:  Marcello Dallio; Mario Romeo; Antonietta Gerarda Gravina; Mario Masarone; Tiziana Larussa; Ludovico Abenavoli; Marcello Persico; Carmelina Loguercio; Alessandro Federico
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

10.  Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats.

Authors:  Naoki Kumashiro; Toru Yoshimura; Jennifer L Cantley; Sachin K Majumdar; Fitsum Guebre-Egziabher; Romy Kursawe; Daniel F Vatner; Ioana Fat; Mario Kahn; Derek M Erion; Xian-Man Zhang; Dongyan Zhang; Vara Prasad Manchem; Sanjay Bhanot; Glenn S Gerhard; Kitt F Petersen; Gary W Cline; Varman T Samuel; Gerald I Shulman
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.